Please sign in to follow a disease.
Ozone injection study: does concentration matter for knee pain?
NCT ID NCT07662512
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a higher concentration of ozone injected into the knee works better than a lower concentration for treating osteoarthritis. 159 patients received one of two ozone strengths and were followed for 3 months. Researchers measured pain, stiffness, and daily function to see if concentration made a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ozone injection
- What this could lead to
- If successful, this could show that a specific ozone concentration provides better pain relief and function for people with knee osteoarthritis.
- What could go wrong
- This is a small, completed trial with only 3 months of follow-up. Results may not apply to all patients, and longer-term benefits or risks are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
159 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 50-85 years with a diagnosis of primary knee osteoarthritis according to the American College of Rheumatology \[12\] criteria, symptomatic knee with KL \[13\] grades II, III and IV, who underwent intra-articular ozone treatment. Exclusion Criteria: * Patients with a history of any intra-articular injection within 3 months before the first ozone injection, a history of previous knee surgery, a diagnosis of malignancy, missing follow-up parameters, bilateral intra-articular knee ozone injection, a secondary knee osteoarthritis diagnosis (trauma, inflammatory joint disease, etc.), patients without demographic and clinical data, or direct radiographs.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gonarthrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sakarya University
Adapazarı, Sakarya, 54010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nerve procedure outlast another for stubborn knee pain?
- Gender-Sensitive therapy: a new hope for knee osteoarthritis?
- Can a smartband and AI app ease knee pain and obesity?
- Can a hong kong robotic system perfect knee alignment with any implant?
- Which injection eases knee pain better: steroid or sugar?
- Can a smartphone app replace physiotherapy for knee pain?